ABSTRACT
Introduction Epidemiologic profile of renal osteodystrophy (ROD) is changing over time and cross-sectional studies provide essential information to improve care and health policies. The Brazilian Registry of Bone Biopsy (REBRABO) is a prospective, national-multicenter cohort that aims to provide clinical information on ROD.
Methods From Aug/2015-Dec/2021, clinical-demographic, laboratory and ROD information were included.
Results Data from 386 individuals were considered. Age was 52 (42–60) years; 198 (51%) were male; 315 (82%) were on hemodialysis; osteitis fibrosa (OF) [163 (42%)] and adynamic bone disease (ABD) [96 (25%)] were the most prevalent forms of ROD; 190 (49%) had the diagnosis of osteoporosis, 82 (56%) vascular calcification; 138 (36%) bone aluminum accumulation and 137 (36%) iron intoxication; patients with high turnover were prone to present a higher prevalence of symptoms.
Conclusions Elevated proportion of patients were diagnosed with OF and ABD, as well as osteoporosis, vascular calcification and clinical symptoms.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee/IRB of State University of Campinas gave ethical approval for this work, under number CAAE: 4131141.6.0000.5404
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Conflict of interest The authors have no conflicts of interest to declare. The results presented in this paper are related to those previously published in part.
Data Availability
All data produced in the present study are available upon reasonable request to the authors
